At Annexon Biosciences we are a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases of the body, brain, and eye. Our novel scientific approach targets upstream C1q to block the classical complement inflammatory cascade before it starts, and its therapeutic candidates are designed to provide meaningful benefits across multiple autoimmune, neurodegenerative and ophthalmic diseases. With proof-of concept data in Guillain-Barré syndrome, Huntington’s disease and geographic atrophy, we are rigorously advancing our mid-to late-stage clinical trials to bring new potential treatments to patients as quickly as possible. At Annexon, you’ll be part of a team committed to making an impact together.

For more information on Annexon and our pipeline, check out our site Annexon Biosciences & Annexon Pipeline. We trade on Nasdaq under the ticker symbol ANNX and are headquartered in Brisbane, CA.

We’re seeking exceptional talent from all backgrounds to fuel our growth. At Annexon, we’re building a diverse, equitable, and inclusive workplace. We value unique perspectives and unconventional paths. If you’re the best candidate for the job, even if you don’t perfectly fit the traditional mold, Learn more about our commitment to diversity, equity, inclusion, and our company culture!

Position:

Reporting to the SVP, Biometrics, this leader independently oversees a team of data managers and technology experts responsible for acquisition and quality of all Annexon clinical trial data. A highly empowered, visible and collaborative role, the Executive Director & Head Clinical Data Management partners cross-functionally to advance medicines to our patients.

Responsibilities include:

- Set the vision for Clinical Data Management through building and maintaining a best-in-class organization that functions as a key strategic partner within Annexon

- Provide operational, strategic, and technical direction to data managers and technology SMEs while maintaining ultimate responsibility for all clinical data within Annexon